Published on 22 Mar 2024 on Zacks via Yahoo Finance
Phibro Animal Health Corporation’s PAHC shares have increased 7% year to date compared with the industry’s rise of 3.7%. The Medical sector has gained 5.9% in the said time frame. The company has a market capitalization of $497.38 million.
The company benefits from high-value new product introductions in the vaccine product line. With its extensive global presence, Phibro has strong potential to expand into emerging markets.
This Zacks Rank 2 (Buy) stock earnings is expected to grow 2.4% in the next five years. PAHC’s ROE for the trailing 12 months was 16.7%, better than the industry average of (9.6%).